Health and life sciences news releases, as the companies issue them.
All releases
27 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.
KALA BIO, today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock"), at a ratio of 1 post-split share for every 30 pre-split shares. The reverse…
Charlotte's Web Holdings, Inc.TSX: CWEBOTCQX: CWBHFTMX Newsfile
Charlotte's Web, a botanical wellness innovation company and a market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended September 30, 2026. All amounts are…
Vesalius is pleased to announce that it will commence trading on the Canadian Securities Exchange ("CSE") under the symbol "VLAB" today, November 12, 2026. "Today marks an important milestone for Vesalius Labs, and I…
Kiora today reported financial results for the third quarter ended September 30, 2026, and provided a business update highlighted by the in-licensing of KIO-401, a late-stage, oral neuroprotective calpain inhibitor. The…
Phio Pharmaceuticals Corp. is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today…
BioHarvest Sciences Inc (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today reported financial results for the three and nine months ended…
Fiscal Q2 2027 net revenue of $29.1 million, Adjusted EBITDA* of $5.1 million, operating income of $2.4 million, and net income of $0.8 million - all quarterly records since fiscal Q4 2025, demonstrating significant…
Delivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health, a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce it has entered into a shares for payables settlement agreement (the "Agreement"), to…
FloraWorks, a cannabinoid biotechnology company, today announced that an independent panel of scientific experts unanimously concluded its proprietary, high-purity cannabinol (CBN) ingredient, TruCBN™, is Generally…
Envoy Medical, a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming…
OS Therapies, the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has initiated a Conditional Marketing Authorisation Application (CMAA) process with the U.K. Medicines and…
Highlights: U.S. patent officially granted by the U.S. Patent Office on September 29, 2026 Covers core innovations underpinning TempraMed's VIVI Cap Smart™, which was launched earlier this yearStrengthens the Company's…
Quinsam is announcing its Q3/2026 results, with net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) versus net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) in Q3/2025.…
Lifordi Immunotherapeutics, Inc., a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented Phase 1 clinical data for…
Rhelion Life Sciences Corp.CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Psyched Wellness Ltd. (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products…
Doseology announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to voluntarily adopt the Semi-Annual Reporting ("SAR") Pilot Program pursuant to…
Digicann is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive Agreement") dated October 31, 2026 and signed on November 4…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),…
Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year. Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower. Operating cash flow of $2.4 million…
Herbal Dispatch, a cannabis commerce and international distribution platform, today issued a progress report on Hero Dispatch (herodispatch.com), the Company's medical cannabis program for Canadian Veterans, and…
Neural announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings Inc. ("CWE").Board of DirectorsThe Company announces that John Durfy has…
Rhelion, an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Doseology, a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it was unable to file its annual audited financial statements, management's discussion…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company…
Doseology a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that Larry Latowsky has resigned as a director of the Company, effective immediately. About…